Industry veteran John Bailey, who served a decade as director of the US Food and Drug Administration’s Office of Cosmetics and Colors, is confident there is a way to meaningfully update federal cosmetics regulations to benefit all stakeholders.
The Senate’s current proposal in the FDA Safety and Landmark Advancements (FDASLA) Act, S. 4348, is not it, he...
Welcome to HBW Insight
Create an account to read this article
Already a subscriber?